Drug–target residence time: critical information for lead optimization
Top Cited Papers
- 31 August 2010
- journal article
- review article
- Published by Elsevier BV in Current Opinion in Chemical Biology
- Vol. 14 (4), 467-474
- https://doi.org/10.1016/j.cbpa.2010.06.176
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- A Slow, Tight Binding Inhibitor of InhA, the Enoyl-Acyl Carrier Protein Reductase from Mycobacterium tuberculosisJournal of Biological Chemistry, 2010
- The dynamics of drug-target interactions: drug-target residence time and its impact on efficacy and safetyExpert Opinion on Drug Discovery, 2010
- Slow Onset Inhibition of Bacterial β-Ketoacyl-acyl Carrier Protein Synthases by ThiolactomycinOnline Journal of Public Health Informatics, 2010
- Synthesis, Kinetic Characterization and Metabolism of Diastereomeric 2-(1-(4-Phenoxyphenylsulfonyl)ethyl)thiiranes as Potent Gelatinase and MT1-MMP InhibitorsChemical Biology & Drug Design, 2009
- Slow Binding Inhibition and Mechanism of Resistance of Non-nucleoside Polymerase Inhibitors of Hepatitis C VirusOnline Journal of Public Health Informatics, 2009
- Slow-Onset Inhibition of the FabI Enoyl Reductase from Francisella tularensis: Residence Time and in Vivo ActivityACS Chemical Biology, 2009
- Mechanism and Inhibition of LpxC: An Essential Zinc-Dependent Deacetylase of Bacterial Lipid A SynthesisCurrent Pharmaceutical Biotechnology, 2008
- Neurokinin 1 Receptor Antagonists: Correlation between in Vitro Receptor Interaction and in Vivo EfficacyThe Journal of pharmacology and experimental therapeutics, 2007
- Biochemical mechanisms of drug action: what does it take for success?Nature Reviews Drug Discovery, 2004
- The Behavior and Significance of Slow‐Binding Enzyme InhibitorsPublished by Wiley ,1988